Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

Superbugs and Superdrugs: Researchers Identify 10 New Immune Systems in Bacteria

by Global Biodefense Staff
February 12, 2018
Salmonella Bacteria

Credit: Shutterstock

Bacteria have been defending themselves from phages—viruses that attack bacterial cells—for billions of years, and, unlocking the immune mechanisms they use to protect themselves has led to the development of powerful molecular biology tools such as restriction enzymes and CRISPR-Cas9.

Now, researchers have discovered 10 more immune systems that bacteria use to protect themselves against phages and plasmids, opening up the possibility to add new tools to the molecular biology toolbox, according to reporting from The Scientist.

“Whenever a complex immune system is discovered, and its mechanism is eventually understood, it can become a very effective tool. Immune systems must be highly selective in identifying specific molecules in order to function well. In molecular biology, this is exactly what we need,” noted Rotem Sorek, a molecular geneticist at the Weizmann Institute of Science in Israel.

This discovery could have a huge impact on AMR as it opens new opportunities, but also brings new challenges.

Taking place in London on 19 – 20th March, the theme for the SMi’s Superbugs & Superdrugs Conference is to tackle the scientific, regulatory and economic challenges to combat AMR.  Hear exclusive case studies on clinical progress and evaluate the latest incentives and funding solutions to build your antibiotic pipeline.

In addition, the University of North Texas Health Science Center will hold a post-conference workshop on 21 March for interactive training on the use of animal models in pre-clinical drug development.

The latest agenda, speaker line-up and attendee list available at www.superbugssuperdrugs.com/globalbiodef

Available to view – Christopher Houchens’ (BARDA) presentation from the last year’s Superbugs & Superdrugs Conference, where you can find information on BARDA’s Mission, Funding Antibacterial Development, National Strategy and Action Plan for CARB, Insufficient Pipeline, Industry Disengagement, BARDA’s Goal, Strategy and Priorities, WHO AMR Priorities, Portfolio Partnerships, What to Expect from CARB-X.

Hear current updates on the above from Mark Albrecht, Health Scientist, HHS/ASPR/BARDA who will be presenting at the Superbugs & Superdrugs Conference this March.

Exclusive interviews with Domingo Gargallo-Viola (ABAC Therapeutics); David Brown (Alchemy Biomedical Consulting), John George (Oppilotech), Lloyd Czaplewski (Chemical Biology Ventures) and Richard Bax (TranScrip Partners) are available at www.superbugssuperdrugs.com/globalbiodef (navigate to Download Centre)

Secure your place at www.superbugssuperdrugs.com/globalbiodef or call Fateja Begum on +44 (0)20 7827 6184

Global Biodefense is an official media partner of Superbugs and Superdrugs 2018.

Tags: AntimicrobialsASPRCRISPREmerging ThreatsEventsHHSMRSA

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC